JPRN-UMIN000015634招募中1 期
Phase I study of EBV specific CTL generated from third party for treatment of EBV associated lymphoproliferative disorder after allogeneic stem cell transplantation - EBV specific CTL for treatment of EBV associated LPD after stem cell transplant
agoya University Graduate School of Medicine, Department of Pediatrics0 个研究点目标入组 9 人开始时间: 2014年11月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe or uncontrollable bacterial, fungal,and viral (except EBV) infection 2. Uncontrollable GVHD 3. Uncontrollable heart failure 4. Psychoses 5.History of allergic reaction to albumin
研究者
相似试验
已完成
1 期
Phase I study of CMV specific CTL generated from third party for treatment of antiviral drug-resistant CMV infection after allogeneic stem cell transplantatioJPRN-UMIN000015556agoya University Graduate School of Medicine, Department of Hematology and Oncology9
已完成
1 期
EBV-TCR-T Cells for EB Virus Infection After HSCTEBV Emia and EBV Positive PTLD After Allogenic HSCTNCT04156217Hebei Yanda Ludaopei Hospital18
撤回
2 期
Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated MalignanciesEBV LymphomasEBV-associated MalignanciesNCT03988582Memorial Sloan Kettering Cancer Center
已完成
1 期
Phase I study of CMV specific CTL for treatment of refractory CMV infection after allogeneic hematopoietic stem cell transplantatioRefractory CMV infection after allogeneic hematopoietic stem cell transplantationJPRN-UMIN000001749Department of Pediatrics, Nagoya University Graduate School of Medicine5
已完成
1 期
A Study of the Safety and Efficacy of EBV Specific T-cell LinesEpstein-Barr Virus InfectionsLymphomaPost-Transplant Lymphoproliferative DisorderNCT02580539Dr. Jean-Sebastien Delisle, MD, PhD12